Nanotechnology · 2023 · 15 citations · 35 references
PharmacyImmunologyPharmaceuticsCancer ImmunologyDrug DeliveryImmunotherapyCancer ImmunotherapyCancer NanomedicineNanomedicineNanoparticle Delivery SystemsVaccine DeliveryVaccine PlatformsAntigen Presenting CellsAntigen-presenting Cell MaturationDendritic Cell TargetingDissolving Microneedle PatchesNanoparticle Vaccine DeliveryNanoparticle Vaccine PlatformsNanoparticle-based ImmunotherapyTriple-negative Breast Cancer Immunotherapy
This work aims at developing a strategy to activate the antigen-presenting cells to enhance the effect of immunotherapy in triple-negative breast cancer (TNBC) through the dissolving microneedle patch (DMNP). In present study, mannosylated chitosan (MCS) nanoparticles (NPs) were designed to target dendritic cells (DCs), and the immunotherapy effect was enhanced by the adjuvant Bacillus Calmette-Guerin polysaccharide (BCG-PSN), achieving the purpose of transdermal immunotherapy for TNBC. Vaccination studies with mice demonstrated that MCS NPs effectively induce DCs maturation in the tumor-draining lymph nodes to stimulate strong immune responses in TNBC. Overall, chitosan-based DMNPs with complex adjuvant constituted a new potent transdermal vaccine delivery platform capable of exploiting more DCs in the skin for effective immunization.
35
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo et al. · New England Journal of Medicine · 2018 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +16
Current Landscape of Immunotherapy in Breast Cancer
Sylvia Adams, Margaret E. Gatti‐Mays, Kevin Kalinsky et al. · JAMA Oncology · 2019 · 409 citations · Full text
Medicine, Immunology, Oncology +17
A melanin-mediated cancer immunotherapy patch
Yanqi Ye, Chao Wang, Xudong Zhang et al. · Science Immunology · 2017 · 380 citations
Medicine, Dermatology, Oncology +16